About 35 percent of women get annual mammograms from age 40 onward. But the value of those screenings has been much debated, because mammograms for people in their 40s catch relatively few cases of breast cancer, generate plenty of false-positive results, and produce some cases of unnecessary treatment.
Despite the success of immunotherapy in the treatment of cancers such as lung or melanoma, it is still not effective in breast cancers for being “cold,” with low infiltration of immune cells. Tumors use strategies to evade immune surveillance by reducing the infiltration of cells that could attack them or by attracting immunosuppressive cells. These strategies can contribute to the poor prognosis observed in breast cancer of young women and make them unresponsive to immunotherapy.
An excerpt from Cancer Screening Decisions, a hands-on tool for clinicians to use with patients as they weigh the personal advantages and disadvantages of cancer screenings. Taking a uniquely visual approach, every page offers clear, colorful graphics to walk you and your patients through every step of the decision-making process for breast cancer.
Understanding Breast Cancer Anatomical Chart is an easy-to-understand user friendly chart which provides essential information about the most common form of cancer in women.